|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cryptocurrency News Articles
ZachXBT Challenges Ansem's Influence Over Low Cap Memecoins
Oct 08, 2024 at 03:18 am
Blockchain investigator Zachary Wolk, known online as ZachXBT, publicly accused crypto influencer Zion “Ansem” Thomas of promoting a series of low market cap memecoins to his large following.

Crypto influencer Zion “Ansem” Thomas is facing accusations from blockchain investigator Zachary Wolk, also known as ZachXBT, of promoting a string of low market cap memecoins to his large following. In an Oct. 5 exchange on X, Wolk took aim at Thomas’ approach, which he described as a “pump and dump” tactic. Specifically, Wolk claims that Thomas is using his influence to artificially inflate coin prices, potentially leading to substantial losses for his followers.
Highlighting the sensitivity of smaller coins to market movements driven by prominent figures, Wolk’s矛头直指Thomas' promotion of Solana-based memecoins. According to the investigator, Thomas is exploiting his large following of over 507,000 users to manipulate prices.
“If you resort to promoting new low cap memecoins every few days to followers as a large account, it’s [because] you have no edge and have to use your followers instead.”
Accusations Stem from Ansem’s Promotion of Memecoins
Wolk pointed to several tokens that Thomas had allegedly promoted, including BODEN, HOBBES, ZEUS, and WYNN, all of which have seen their values plummet. This stands in contrast to other coins, like Chainlink (LINK), which is down 90% against Bitcoin year-to-date, highlighting the risks associated with such low-cap coins.
In response, Thomas questioned why promoting “lowcaps” was labeled as “grifting” and defended his support for these coins. He highlighted Dogwifhat (WIF) as an example, which had a market cap of $100,000 at the time of his promotion and later surged to $4.8 billion in March.
“The ‘low cap garbage’ you talk about has dominated 90% of retail mindshare in crypto over the past year.”
BODEN, HOBBES, ZEUS, WYNN Memecoins See Massive Declines
Many of the coins that ZachXBT mentioned have seen sharp declines in value. For instance, BODEN, a memecoin themed around President Joe Biden, is down almost 99% from its all-time high of $1.04 billion in April, data from CoinGecko shows. Similarly, HOBBES, ZEUS, and WYNN have all dropped by approximately 98% from their peaks.
Disclaimer:info@kdj.com
The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!
If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.
-
-
- Datavecta Forges Global Community Ecosystem to Power International Growth Through Advanced SEO Strategy
- Sep 30, 2026 at 07:55 pm
- Datavecta is building a global community ecosystem to enhance international growth, leveraging advanced SEO strategies and technology-driven services for a connected intelligent trading future.
-
- Illinois Rolls Out Draft Rules for 0.2% Crypto Transaction Tax, Set for 2027
- Sep 30, 2026 at 12:05 pm
- Illinois unveils draft regulations for its upcoming 0.2% digital asset transaction tax, impacting exchanges, transfers, and custody services starting January 1, 2027. The tax applies to the gross value of transactions, not investment gains.
-
-
- Apeing Leads the Charge: Unveiling the Next 100x Crypto Watchlist and 6 Coins to Eye
- Sep 30, 2026 at 12:03 pm
- Amidst a dynamic crypto market, Apeing's presale momentum, coupled with established players like Solana and TRON, is redefining the 100x crypto narrative, offering both early-stage opportunities and proven network strength.
-
-
- OpenAI Unveils GPT-6.1 Sol and Ultrafast Tier, While AstraZeneca Invests Big in Summit Therapeutics
- Sep 30, 2026 at 08:05 am
- OpenAI rolls out GPT-6.1 Sol, offering near-Astra performance at a fraction of the cost, alongside a new 'Ultrafast' speed tier. Meanwhile, AstraZeneca makes a significant $2 billion investment in oncology firm Summit Therapeutics.
-
-
































